Analysts’ Viewpoint on Recto-vaginal Fistula Treatment Market Scenario
Elective procedures have been postponed indefinitely in the recto-vaginal fistula treatment market due to the ongoing coronavirus pandemic. Healthcare stakeholders are increasing the availability of tests such as contrast tests, blue dye test, and CT scan to identify fistulas. However, the high number of morbidity and mortality even after recto-vaginal fistula treatment is emerging as a challenge to healthcare practitioners. Hence, practitioners should increase awareness about pre-appointment restrictions, considerations for surgery and listing key medical information to enable proper diagnosis of recto-vaginal fistula. It has been found that presence of cancerous tumor in regions such as uterus, rectum, vagina, anal canal or cervix, can lead to the development of recto-vaginal fistula.
The rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula is driving the global recto-vaginal fistula treatment market. Crohn's disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. A large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, suffering from Crohn’s disease increases the risk of this condition. Hence, the prevalence of recto-vaginal fistula is projected to rise during the forecast period, owing to the increase in incidence of Crohn’s disease.
Delivery-related injuries is a most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aids a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period. Such findings are steering the growth of the recto-vaginal fistula treatment market.
Stakeholders in the recto-vaginal fistula treatment market are adopting contingency planning to prevent disruption across patient demands, supply of materials, and availability of diagnostic services. Since elective procedures have been postponed indefinitely due to the ongoing coronavirus pandemic, medical practitioners are increasing awareness about different tests for identifying fistulas, medications, and lifestyle or home remedies to reduce burden on healthcare facilities. As such, telehealth and mobile apps are anticipated to register high growth post the pandemic. Healthcare stakeholders are striking a balanced relationship with suppliers and ecosystem partners to improve medical outcomes. They are increasing the availability of life-altering therapeutics.
Recto-vaginal fistula can be described as abnormal epithelial line connected between the rectum and vagina. Fistulas can be the outcome of acquired etiologies or congenital malformations. Recto-vaginal fistulas can also be caused due to childbirth. Obstetric injury with a fourth or a third degree perineal tear or prolonged labor with necrosis of the part or episiotomy could result in recto-vaginal fistula. Infection, breakdown of the repair, or improper repair can lead to the development of fistula. Infections caused within the recto-vaginal septum can lead to the condition. Bartholin gland infections and crypto-glandular ano-rectal abscess drains cause low recto-vaginal fistula. This explains why the recto-vaginal fistula treatment market is positioned for healthy growth during the forecast period.
Hysterectomy is performed as a result of infection caused due to fistula. Lymph granuloma venereum and tuberculosis can result in recto-vaginal fistula. Primary classification of the condition is carried out with the help of etiology, size, and location. It categorizes the criteria for recto-vaginal fistulas as complex or simple. Classification of fistula is performed to plan proper treatment and appropriate therapy. Fistulas greater than 2.5 cm in diameter are termed as large and those less than 2.5 cm are considered small. Hence, healthcare practitioners in the recto-vaginal fistula treatment market are increasing R&D to boost availability of therapeutics.
North America is anticipated to dominate the global recto-vaginal fistula treatment market from 2021 to 2031. This can be attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development (R&D), and government funding for life sciences research. Additionally, well-established and high quality infrastructure are driving the North America recto-vaginal fistula treatment market. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in R&D activities, increase in government initiatives for improving healthcare, and surge in focus of key players on building or strengthening presence in the region.
Governments of developing countries are making significant investments to modernize healthcare infrastructure in their respective countries, which is likely to increase access to healthcare. This is projected to fuel the demand for recto-vaginal fistula treatment.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 550.8 Mn |
|
Market Forecast Value in 2031 |
US$ 1,034.3 Mn |
|
Growth Rate (CAGR) |
5.7% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Recto-vaginal Fistula Treatment Market – Segmentation
TMR’s study on the global recto-vaginal fistula treatment market includes information divided into three segments: type, end-user, indication, treatment, and region. Changing industry trends and other market dynamics associated with these segments of the global recto-vaginal fistula treatment market are discussed in detail.
| Type |
|
| End-user |
|
| Indication |
|
| Treatment |
|
| Region |
|
Recto-vaginal fistula treatment market is expected to cross the value of US$ 1 Bn by the end of 2031
Recto-vaginal fistula treatment market is estimated to expand at a CAGR of 5.7% from 2021 to 2031
Recto-vaginal fistula treatment market is driven by rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula.
The high recto-vaginal fistula segment is projected to account for major share of the market by 2031
Key players operating in the global market include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Recto-vaginal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Advancements & Innovations in Treatment Methods/Medications
5.2. Disease Epidemiology Analysis
5.3. Key Industry Events (mergers, acquisitions, agreements / partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. High Recto-vaginal Fistula
6.3.2. Low Recto-vaginal Fistula
6.3.3. Midzone Fistula
6.4. Market Attractiveness Analysis, by Type
7. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Treatment
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Treatment, 2017–2031
8.3.1. Medication
8.3.1.1. Antibiotics
8.3.1.2. Biologics Therapy
8.3.2. Surgery
8.3.2.1. Sphincteroplasty Procedure
8.3.2.2. Endorectal Advancement Flap Procedure
8.3.2.3. Others
8.4. Market Attractiveness Analysis, by Treatment
9. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Indication, 2017–2031
9.3.1. Crohn's Disease
9.3.2. Delivery-related Injuries
9.3.3. Cancerous Tumor Treatment
9.3.4. Others
9.4. Market Attractiveness Analysis, by Indication
10. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Recto-vaginal Fistula Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. High Recto-vaginal Fistula
11.2.2. Low Recto-vaginal Fistula
11.2.3. Midzone Fistula
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Market Value Forecast, by Treatment, 2017–2031
11.4.1. Medication
11.4.1.1. Antibiotics
11.4.1.2. Biologics Therapy
11.4.2. Surgery
11.4.2.1. Sphincteroplasty Procedure
11.4.2.2. Endorectal Advancement Flap Procedure
11.4.2.3. Others
11.5. Market Value Forecast, by Indication, 2017–2031
11.5.1. Crohn's Disease
11.5.2. Delivery-related Injuries
11.5.3. Cancerous Tumor Treatment
11.5.4. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By End-user
11.7.3. By Treatment
11.7.4. By Indication
11.7.5. By Country
12. Europe Recto-vaginal Fistula Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. High Recto-vaginal Fistula
12.2.2. Low Recto-vaginal Fistula
12.2.3. Midzone Fistula
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Market Value Forecast, by Treatment, 2017–2031
12.4.1. Medication
12.4.1.1. Antibiotics
12.4.1.2. Biologics Therapy
12.4.2. Surgery
12.4.2.1. Sphincteroplasty Procedure
12.4.2.2. Endorectal Advancement Flap Procedure
12.4.2.3. Others
12.5. Market Value Forecast, by Indication, 2017–2031
12.5.1. Crohn's Disease
12.5.2. Delivery-related Injuries
12.5.3. Cancerous Tumor Treatment
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By End-user
12.7.3. By Treatment
12.7.4. By Indication
12.7.5. By Country/Sub-region
13. Asia Pacific Recto-vaginal Fistula Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. High Recto-vaginal Fistula
13.2.2. Low Recto-vaginal Fistula
13.2.3. Midzone Fistula
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Market Value Forecast, by Treatment, 2017–2031
13.4.1. Medication
13.4.1.1. Antibiotics
13.4.1.2. Biologics Therapy
13.4.2. Surgery
13.4.2.1. Sphincteroplasty Procedure
13.4.2.2. Endorectal Advancement Flap Procedure
13.4.2.3. Others
13.5. Market Value Forecast, by Indication, 2017–2031
13.5.1. Crohn's Disease
13.5.2. Delivery-related Injuries
13.5.3. Cancerous Tumor Treatment
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By End-user
13.7.3. By Treatment
13.7.4. By Indication
13.7.5. By Country/Sub-region
14. Latin America Recto-vaginal Fistula Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. High Recto-vaginal Fistula
14.2.2. Low Recto-vaginal Fistula
14.2.3. Midzone Fistula
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Hospitals
14.3.2. Ambulatory Surgical Centers
14.3.3. Others
14.4. Market Value Forecast, by Treatment, 2017–2031
14.4.1. Medication
14.4.1.1. Antibiotics
14.4.1.2. Biologics Therapy
14.4.2. Surgery
14.4.2.1. Sphincteroplasty Procedure
14.4.2.2. Endorectal Advancement Flap Procedure
14.4.2.3. Others
14.5. Market Value Forecast, by Indication, 2017–2031
14.5.1. Crohn's Disease
14.5.2. Delivery-related Injuries
14.5.3. Cancerous Tumor Treatment
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of LATAM
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By End-user
14.7.3. By Treatment
14.7.4. By Indication
14.7.5. By Country/Sub-region
15. Middle East & Africa Recto-vaginal Fistula Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. High Recto-vaginal Fistula
15.2.2. Low Recto-vaginal Fistula
15.2.3. Midzone Fistula
15.3. Market Value Forecast, by End-user, 2017–2031
15.3.1. Hospitals
15.3.2. Ambulatory Surgical Centers
15.3.3. Others
15.4. Market Value Forecast, by Treatment, 2017–2031
15.4.1. Medication
15.4.1.1. Antibiotics
15.4.1.2. Biologics Therapy
15.4.2. Surgery
15.4.2.1. Sphincteroplasty Procedure
15.4.2.2. Endorectal Advancement Flap Procedure
15.4.2.3. Others
15.5. Market Value Forecast, by Indication, 2017–2031
15.5.1. Crohn's Disease
15.5.2. Delivery-related Injuries
15.5.3. Cancerous Tumor Treatment
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of MEA
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By End-user
15.7.3. By Treatment
15.7.4. By Indication
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Pfizer Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Company Financials
16.2.1.3. Growth Strategies
16.2.1.4. SWOT Analysis
16.2.2. GlaxoSmithKline plc
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Company Financials
16.2.2.3. Growth Strategies
16.2.2.4. SWOT Analysis
16.2.3. Sanofi S.A.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Company Financials
16.2.3.3. Growth Strategies
16.2.3.4. SWOT Analysis
16.2.4. Takeda Pharmaceutical Company Limited
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Company Financials
16.2.4.3. Growth Strategies
16.2.4.4. SWOT Analysis
16.2.5. Johnson & Johnson Services, Inc.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Company Financials
16.2.5.3. Growth Strategies
16.2.5.4. SWOT Analysis
16.2.6. W. L. Gore & Associates, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Company Financials
16.2.6.3. Growth Strategies
16.2.6.4. SWOT Analysis
16.2.7. Mount Sinai Hospital
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Company Financials
16.2.7.3. Growth Strategies
16.2.7.4. SWOT Analysis
16.2.8. Tubingen University Hospital
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Company Financials
16.2.8.3. Growth Strategies
16.2.8.4. SWOT Analysis
16.2.9. St. Mark's Hospital
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Company Financials
16.2.9.3. Growth Strategies
16.2.9.4. SWOT Analysis
16.2.10. Apollo Hospitals Enterprise Ltd.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Company Financials
16.2.10.3. Growth Strategies
16.2.10.4. SWOT Analysis
16.2.11. Other Prominent Players
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Company Financials
16.2.11.3. Growth Strategies
16.2.11.4. SWOT Analysis
List of Tables
Table 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 04: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 05: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 06: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 10: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 12: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 13: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 14: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 19: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 20: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 21: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 23: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 24: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 26: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 27: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 28: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 29: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 30: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 31: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 32: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 33: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 34: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 35: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 37: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 38: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 39: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 40: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031
Table 41: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031
Table 42: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031
List of Figures
Figure 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Recto-vaginal Fistula Treatment Market Value Share, by Type, 2020
Figure 03: Global Recto-vaginal Fistula Treatment Market Value Share, by Indication, 2020
Figure 04: Global Recto-vaginal Fistula Treatment Market Value Share, by End-user, 2020
Figure 05: Global Recto-vaginal Fistula Treatment Market Value Share, by Treatment, 2020
Figure 06: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 07: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 08: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by High Recto-vaginal Fistula, 2017–2031
Figure 09: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Low Recto-vaginal Fistula, 2017–2031
Figure 10: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Midzone Fistula, 2017–2031
Figure 11: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 12: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 13: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 14: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 15: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Others, 2017–2031
Figure 16: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 17: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 18: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Medication, 2017–2031
Figure 19: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Surgery, 2017–2031
Figure 20: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 21: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 22: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Crohn's Disease, 2017–2031
Figure 23: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031
Figure 24: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Cancerous Tumor Treatment, 2017–2031
Figure 25: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031
Figure 26: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Region, 2020 and 2031
Figure 27: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Region, 2021–2031
Figure 28: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 29: North America Recto-vaginal Fistula Treatment Market Value Share, by Country, 2020–2031
Figure 30: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country, 2021–2031
Figure 31: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 32: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 33: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 34: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 35: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 36: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 37: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 38: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 39: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Europe Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031
Figure 41: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 42: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 43: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 44: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 45: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 46: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 47: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 48: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 49: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 50: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031
Figure 52: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 53: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 54: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 55: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 56: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 57: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 58: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 59: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 60: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 61: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 62: Latin America Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031
Figure 63: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 64: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 65: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 66: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 67: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 68: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 69: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 70: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 71: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 72: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 73: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031
Figure 74: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 75: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
Figure 76: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031
Figure 77: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
Figure 78: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Figure 79: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 80: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 81: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
Figure 82: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031
Figure 83: Global Recto-vaginal Fistula Treatment Market Share, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Recto-vaginal Fistula Treatment Market
